No. 21-1283

Animal Science Products, Inc., et al. v. Hebei Welcome Pharmaceutical Co. Ltd., et al.

Lower Court: Second Circuit
Docketed: 2022-03-23
Status: Denied
Type: Paid
Amici (2) Experienced Counsel
Tags: antitrust antitrust-law federal-rule-44.1 foreign-conduct foreign-law judicial-interpretation prescriptive-comity sherman-act statutory-interpretation
Key Terms:
Antitrust JusticiabilityDoctri
Latest Conference: 2022-09-28
Question Presented (AI Summary)

Whether U.S. courts may reinterpret the Sherman Act using a discretionary ten-factor balancing test under the doctrine of prescriptive comity

Question Presented (OCR Extract)

QUESTIONS PRESENTED Even though the application of U.S. antitrust laws to foreign conduct “can interfere with a foreign nation’s ability independently to regulate its own commercial affairs,” this Court has “long held that application of our antitrust laws to foreign anticompetitive conduct is nonetheless reasonable, and hence consistent with principles of prescriptive comity, insofar as they reflect a legislative effort to redress domestic antitrust injury that foreign anticompetitive conduct has caused.” F. Hoffmann-La Roche Lid. v. Empagran S.A., 542 U.S. 155, 165 (2004). It is “well established that Congress has exercised [prescriptive] jurisdiction under the Sherman Act” to regulate “foreign conduct that was meant to produce and did in fact produce some substantial effect in the United States,” Hartford Fire Ins. Co. v. California, 509 U.S. 764, 796 & n.22 (1998). The questions presented are: 1. Whether, despite this Court’s “well established” interpretation of the Sherman Act, U.S. courts may reinterpret the same text of that Act case by case using a discretionary ten-factor balancing test under the doctrine of prescriptive comity. 2. Whether a court interpreting the meaning of foreign law under Federal Rule of Civil Procedure 44.1 is limited to the “face” of written legal materials, as the decision below held, or may also consider evidence as to how foreign law is implemented and enforced that would be relevant to the interpretive inquiry in the foreign legal system.

Docket Entries

2022-10-03
Petition DENIED.
2022-07-06
DISTRIBUTED for Conference of 9/28/2022.
2022-07-06
Reply of petitioners Animal Science Products Inc., et al. filed. (Distributed)
2022-06-21
Brief of respondents Hebei Welcome Pharmaceutical Co. Ltd., et al. in opposition filed.
2022-04-22
Brief amicus curiae of Chamber of Commerce of the United States filed.
2022-04-13
Motion to extend the time to file a response is granted and the time is extended to and including June 21, 2022.
2022-04-12
Motion to extend the time to file a response from April 22, 2022 to June 21, 2022, submitted to The Clerk.
2022-04-11
Brief amici curiae of Professors William S. Dodge and Paul B. Stephan filed.
2022-03-21
Petition for a writ of certiorari filed. (Response due April 22, 2022)
2021-12-16
Application (21A227) granted by Justice Sotomayor extending the time to file until March 21, 2022.
2021-12-13
Application (21A227) to extend the time to file a petition for a writ of certiorari from January 19, 2022 to March 20, 2022, submitted to Justice Sotomayor.

Attorneys

Animal Science Products Inc., et al.
Michael Julian GottliebWillkie Farr & Gallagher LLP, Petitioner
Michael Julian GottliebWillkie Farr & Gallagher LLP, Petitioner
Chamber of Commerce of the United States of America
Michael Francis MurrayPaul Hastings LLP, Amicus
Michael Francis MurrayPaul Hastings LLP, Amicus
Hebei Welcome Pharmaceutical Co. Ltd., et al.
Jonathan M. JacobsonWilson Sonsini Goodrich & Rosati PC, Respondent
Jonathan M. JacobsonWilson Sonsini Goodrich & Rosati PC, Respondent
Professors William S. Dodge and Paul B. Stephan
Jonathan S. MasseyMassey & Gail LLP, Amicus
Jonathan S. MasseyMassey & Gail LLP, Amicus